Alkeon Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-462,904
Closed -$29.7M 145
2018
Q4
$29.7M Sell
462,904
-4,691
-1% -$346K 0.19% 93
2018
Q3
$41.8M Sell
467,595
-37,483
-7% -$3.31M 0.2% 83
2018
Q2
$40.1M Sell
505,078
-422,704
-46% -$35.1M 0.19% 84
2018
Q1
$82.8M Sell
927,782
-100,675
-10% -$9.66M 0.43% 57
2017
Q4
$107M Sell
1,028,457
-747,532
-42% -$84.3M 0.63% 44
2017
Q3
$259M Buy
1,775,989
+7,000
+0.4% +$953K 1.86% 10
2017
Q2
$230M Sell
1,768,989
-42,566
-2% -$5.22M 1.85% 10
2017
Q1
$225M Sell
1,811,555
-7,000
-0.4% -$838K 3.89% 4
2016
Q4
$210M Buy
1,818,555
+55,460
+3% +$6.18M 4.15% 4
2016
Q3
$184M Sell
1,763,095
-11,350
-0.6% -$1.23M 3.47% 6
2016
Q2
$186M Buy
1,774,445
+1,545
+0.1% +$160K 3.59% 4
2016
Q1
$177M Sell
1,772,900
-1,100
-0.1% -$113K 3.66% 6
2015
Q4
$212M Sell
1,774,000
-15,500
-0.9% -$1.79M 4.31% 5
2015
Q3
$209M Buy
1,789,500
+43,000
+2% +$5.34M 4.36% 4
2015
Q2
$202M Hold
1,746,500
3.94% 6
2015
Q1
$201M Sell
1,746,500
-5,000
-0.3% -$597K 3.85% 6
2014
Q4
$196M Sell
1,751,500
-208,000
-11% -$21.9M 3.83% 3
2014
Q3
$186M Buy
1,959,500
+265,500
+16% +$24M 3.68% 4
2014
Q2
$145M Buy
1,694,000
+557,060
+49% +$42.4M 2.66% 12
2014
Q1
$79.4M Sell
1,136,940
-1,130,000
-50% -$89.5M 1.34% 29
2013
Q4
$192M Buy
2,266,940
+1,102,000
+95% +$87.2M 3.23% 6
2013
Q3
$89.8M Buy
+1,164,940
New +$81.6M 1.75% 24

Other funds holding CELG

Alkeon Capital Management's CELG Position: Q1 2019 in Review

Alkeon Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 462,904 shares — an estimated $29.7M sold.

Alkeon Capital Management first reported a position in CELG in Q3 2013 and held it in 22 quarters. The position peaked at $259M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Alkeon Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Alkeon Capital Management sold 462,904 Celgene Corp shares in Q1 2019, an estimated $29.7M.
  • Alkeon Capital Management first reported a position in Celgene Corp in Q3 2013 and held it in 22 quarters.
  • Alkeon Capital Management's Celgene Corp position peaked at $259M in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Alkeon Capital Management's 13F filing for Q1 2019, filed 15 May 2019.